In total, 11/39 patients (28.2%) had a confirmed molecular diagnosis, including known IEIs such as Jacobsen syndrome, 22q11.2 deletion syndrome, and XLP2, as well as syndromes not yet officially recognized as IEIs (e.g., MYT1L, Down syndrome). Here, MYT1L is linked to Jacobsen syndrome.